MedTrace Logo

Future Optimal Research and Care Evaluation - Aortic Stenosis

NCT06168123 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2024-12-03

No results posted yet for this study

Summary

In the past decade the treatment of aortic valve stenosis has rapidly changed. At first, transcatheter aortic valve implantation (TAVI) was a last resort option for inoperable patients. Nowadays, it more and more becomes an alternative to surgical aortic valve replacement (SAVR) - also in younger and lower risk patients. This poses important questions to clinical practise regarding the optimal life-time management of each individual patient. Which involves (durability of) treatment modality (surgical vs. transcatheter vs. conservative treatment) as well as the duration and type of the required antithrombotic treatment.

Objective: to evaluate the effect of treatment modality (surgical vs. transcatheter vs. conservative treatment) and its complications on quality of life and survival in AoS patients.

Conditions

  • Severe Aortic Valve Stenosis
  • Moderate Aortic Valve Stenosis

Interventions

BEHAVIORAL

Quality of life questionnaires will be assessed in addition to standard care

Quality of life questionnaires will be assessed in addition to standard care

Sponsors & Collaborators

  • St. Antonius Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
110 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-27
Primary Completion
2027-08-01
Completion
2027-08-01

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06168123 on ClinicalTrials.gov